In Vivo Genome-Wide CRISPR Screening Identifies CITED2 as a Driver of Prostate Cancer Bone Metastasis

Using genome-wide CRISPR activation and inhibition screens investigators identified multiple drivers and suppressors of prostate cancer metastasis.